09.11.2017 • TopicsAfricaImperialpharmaceutical logistics

Challenges for Pharmaceutical Logistics in South Africa

Dr. Iain Barton, Executive Healthcare, Imperial Logistics Group, South Africa
Dr. Iain Barton, Executive Healthcare, Imperial Logistics Group, South Africa

In a worldwide comparison Africa is currently a very small and economically sub-scale and micro-fragmented market. It accounts for just two percent of the global pharmaceutical market, and when South Africa is excluded, has approximately half a percent of the global market spread across about 40 different countries in Sub-Saharan Africa. In Africa, there is a constant shortage of skilled workers and supply chain infrastructure. Storage capacity and quality storage facilities are scarce. Building a new pharmaceutical warehouse poses its own challenges, as engineering specs and limited oversight may result in defects like concrete that crumbles under the wheels of a forklift. With the exception of South Africa, most African countries also have poor road infrastructure, fragmented airline routes and insufficient flight connections for airfreight, which compromises pharmaceutical logistics.

Security risks prevalent in Africa’s pharmaceutical supply chain include not just theft, but also sub-standard counterfeit products that can jeopardize the reputation of established brands. One of the biggest obstacles hampering healthcare delivery in Africa is the lack of harmony in drug regulations across the continent. Since each country has different regulations, product registration becomes extremely complex and costly. As a result, many drug companies are not registering medicines in African countries.

As Africa’s leading partner in the healthcare supply chain, Imperial has taken up the continent’s challenges, and offers holistic supply chain solutions to deliver essential medicines to those in need. For multinational pharmaceutical manufacturers, Imperial’s solutions mitigate the risks and complexity of doing business in Africa. With multiple clients benefiting from its established, proven network, infrastructure, people, systems and continuous improvement initiatives, Imperial creates scale and reduces the risks for global companies in African markets.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
19.03.2025 • TopicsStrategy

The Future of Demand for Chemicals

The chemical industry is shifting to sustainability-related products, with demand growing 4.5 times faster than conventional ones. Companies must revise their market strategies to capitalize on this opportunity.

Photo
14.05.2025 • TopicsPharma

Pharma Outlook 2025

The environment for pharma in 2025 is diverse and challenging: New treatment options are being brought to market in ever shorter cycles.